Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Wasan, Harpreet, Meade, Angela M, Adams, Richard, Wilson, Richard, Pugh, Cheryl, Fisher, David, Sydes, Benjamin, Madi, Ayman, Sizer, Bruce, Lowdell, Charles, Middleton, Gary, Butler, Rachel, Kaplan, RVolume:
15
Langue:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70106-8
Date:
May, 2014
Fichier:
PDF, 442 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
